Smart Nanomaterials to Combat the Spread of Viral Infections: Advanced Strategies for the Prevention of Viral Infections, 2023, Pages 97-123
This content supports the SDG Goal 3: Good health and well-being by discussing the role of multifunctional metal nanoparticles as antiviral therapeutic agents and nanovaccines against different viruses, including human immunodeficiency virus, hepatitis viruses, influenza A virus, herpes simplex virus, and severe acute respiratory syndrome coronavirus 2.
This content aligns with Goal 10: Reduced Inequalities by examining the social determinants of health, food, and nutritional inequities.
Elsevier,
Clinical Decision Support and Beyond (Third Edition)
Progress and Opportunities in Knowledge-Enhanced Health and Healthcare
2023, Pages 707-714
Clinical Decision support provides an effective tool to minimize many of the drivers of health disparities in healthcare. There is promising evidence that these tools can serve to promote equity across the healthcare spectrum supporting SDG 3. However, future iterations require a focus on equity from the start and inclusive and sustainable development, implementation, and evaluation practices.
Elsevier,
Emerging Practices in Telehealth
Best Practices in a Rapidly Changing Field
2023, Pages 163-182
The need and opportunities for global health strategies to leverage the power of digital health technology to improve healthcare outcomes are growing. Telehealth and other digital health products and services are becoming increasingly important in this effort, and methodical strategies should be used to evaluate the need, application, integration, maintenance, and scaling of such solutions. With the correct attention upon these areas, digital health can serve as a catalyst to improve healthcare outcomes and reduce disparities across the world, supporting SDG3.
This content aligns with Goal 3: Good Health. Infectious hepatitis during childhood is classified both for clinical and academic purposes as acute or chronic, the latter carrying the highest burden of morbidity and mortality.
This content aligns with Goal 3: Good Health and summarizes and highlights the principles of therapy for AIH of importance to pathologists.
This content aligns with Goal 3: Good Health and Wellbeing by highlighting hepatic manifestations of HIV infection.
Elsevier,
The Thinking Healthcare System: Artificial Intelligence and Human Equity, 2023, Pages 99-129
This chapter advances the UN SDG Goal 3: Good Health and Goal 10: Reduced Inequalities by introducing the AI transformation of public health (PubHealth) uniting healthcare systems with the central terms, concepts, and history of PubHealth from ancient quarantines to modern vaccines including milestone developments as successful responses to chronic and infectious diseases, sanitation, workplace safety, poverty, and wars.
Elsevier,
Clinical Decision Support and Beyond (Third Edition): Progress and Opportunities in Knowledge-Enhanced Health and Healthcare, 2023, Pages 715-725
This chapter advances the UN SDG Goal 3: Good Health and Goal 10: Reduced Inequalities by discussing the components of a technical infrastructure to support PHM, including data sources (registries, electronic health records), data analytics tools, patient outreach and engagement tools, and patient tracking dashboards along with real-world examples of PHM programs focused on chronic disease management, genetic testing for hereditary cancers, colorectal cancer screening, COVID-19 testing and vaccination, and tobacco cessation.
This content supports the SDG Goal 3: Good health and well-being by providing the current knowledge regarding standard therapy and suggestions based on the literature for AIH patients being nonresponders to standard therapy and difficult-to-manage AIH patients to standard therapy.
